AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.
A new study from Oregon Health & Science University has uncovered how small molecules within bacteria interact with proteins, ...
With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...
A global team has made a significant advance in understanding how bacterial plasmids contribute to antibiotic resistance.
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger ...
Integrating AI tools into drug discovery introduces a mix of opportunities and challenges for startups and large pharmaceutical companies.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback